The bimodality effect was obtained before for different parameters of the nanoholes [12, 15, 16] that are the final result of local droplet etching.
The following demographic data and medical history information were obtained before randomization for every eligible patient: gender, age, weight, height, indication for colonoscopy, previous colonoscopy, date of last colonoscopy, previous polyp resection, and familial history of colorectal cancer.
Bronchial secretions were obtained before and for 5 consecutive h after Tc-99 m administration.
Each mouse served as its own control: blood was obtained before exercise for baseline values and a repeat blood draw was obtained immediately after exercise.
Written informed consent was obtained before taking blood for microbiological investigations, if feasible.
Ten millilitre of venous blood was obtained before the procedure for isolation of peripheral blood mononuclear cells (PBMC).
Biological replicates of aCGH experiments also demonstrated high reproducibility: two independent research core biopsies were obtained before neoadjuvant chemotherapy for five patients.
For the genetic analysis, written informed consent (from the subject or from the responsible guardian if the subject was incapable) was obtained, before study initiation, for blood collection and genotyping.
Blood samples were obtained before initial treatment for measurement of CRP, albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, white blood cell count, neutrophil, lymphocyte, platelet (Plt) count, prothrombin time, and α-fetoprotein level (AFP).
